Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
181,259,081
-
Total 13F shares
-
21,097,881
-
Share change
-
-658,721
-
Total reported value
-
$208,659,435
-
Price per share
-
$9.89
-
Number of holders
-
53
-
Value change
-
-$4,939,947
-
Number of buys
-
25
-
Number of sells
-
22
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q3 2022
As of 30 Sep 2022,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,097,881 shares.
The largest 10 holders included
FMR LLC, Casdin Capital, LLC, BlackRock Inc., Avidity Partners Management LP, FEDERATED HERMES, INC., VANGUARD GROUP INC, Deep Track Capital, LP, MARSHALL WACE, LLP, HHLR ADVISORS, LTD., and DAFNA Capital Management LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.